A critical reflection on the use of improvement science approaches in public health.

Improvement science causality evaluation quality improvement

Journal

Scandinavian journal of public health
ISSN: 1651-1905
Titre abrégé: Scand J Public Health
Pays: Sweden
ID NLM: 100883503

Informations de publication

Date de publication:
May 2022
Historique:
pubmed: 19 2 2021
medline: 4 5 2022
entrez: 18 2 2021
Statut: ppublish

Résumé

'Improvement science' is used to describe specific quality improvement methods (including tests of change and statistical process control). The approach is spreading from clinical settings to population-wide interventions and is being extended from supporting the adoption of proven interventions to making generalisable claims about new interventions. The objective of this narrative review is to evaluate the strengths and risks of current improvement science practice, particularly in relation to how they might be used in population health. A purposive sampling of published studies to identify how improvement science methods are being used and for what purpose. The setting was Scotland and studies that focused on health and wellbeing outcomes. We have identified a range of improvement science approaches which provide practitioners with accessible tools to assess small-scale changes in policy and practice. The strengths of such approaches are that they facilitate consistent implementation of interventions already known to be effective and motivate and empower staff to make local improvements. However, we also identified a number of potential risks. In particular, their use to assess the effectiveness of new interventions often seems to pay insufficient attention to random variation, measurement bias, confounding and ethical issues.

Identifiants

pubmed: 33596733
doi: 10.1177/1403494821990245
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

389-394

Auteurs

Colin M Fischbacher (CM)

Public Health Scotland, Edinburgh, UK.

Jim Lewsey (J)

Institute of Health and Wellbeing, University of Glasgow, UK.

Jill Muirie (J)

Glasgow Centre for Population Health, Glasgow, UK.

Gerry McCartney (G)

Public Health Scotland, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH